Villere ST Denis J & Co. LLC Trims Position in Teleflex Incorporated (NYSE:TFX)

Villere ST Denis J & Co. LLC cut its position in Teleflex Incorporated (NYSE:TFX) by 21.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 136,980 shares of the medical technology company’s stock after selling 37,878 shares during the period. Teleflex comprises 2.8% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 13th largest holding. Villere ST Denis J & Co. LLC owned approximately 0.29% of Teleflex worth $33,878,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Oregon Public Employees Retirement Fund increased its stake in shares of Teleflex by 1.2% in the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after purchasing an additional 46 shares in the last quarter. Cromwell Holdings LLC boosted its position in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 49 shares during the last quarter. Crossmark Global Holdings Inc. boosted its position in shares of Teleflex by 1.9% during the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after acquiring an additional 53 shares during the last quarter. Empirical Finance LLC boosted its position in shares of Teleflex by 3.9% during the first quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company’s stock worth $354,000 after acquiring an additional 58 shares during the last quarter. Finally, SRS Capital Advisors Inc. boosted its position in shares of Teleflex by 0.3% during the second quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company’s stock worth $4,107,000 after acquiring an additional 62 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TFX. Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial restated a “hold” rating and set a $227.00 target price (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Stephens increased their price objective on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Teleflex currently has a consensus rating of “Moderate Buy” and an average price target of $259.25.

Insider Transactions at Teleflex

In other news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now owns 5,496 shares in the company, valued at approximately $1,313,159.28. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.43% of the company’s stock.

Teleflex Price Performance

TFX stock opened at $195.53 on Friday. The company has a fifty day simple moving average of $235.39 and a two-hundred day simple moving average of $223.70. The firm has a market capitalization of $9.08 billion, a P/E ratio of 38.87, a price-to-earnings-growth ratio of 2.07 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52 week low of $194.58 and a 52 week high of $257.85.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.11. The firm had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business’s revenue was up 2.4% on a year-over-year basis. During the same quarter last year, the business earned $3.64 EPS. Analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a $0.34 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.